Status:
COMPLETED
Tissue Penetration of Antibiotics in Obesity
Lead Sponsor:
Washington University School of Medicine
Conditions:
Obesity
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate cefoxitin pharmacokinetics in obese surgical patients.
Eligibility Criteria
Inclusion
- BMI \<25 and \>40
- Scheduled for elective abdominal or pelvic surgery
- Surgical plan for intraoperative cefoxitin prophylaxis
- Able to provide informed consent
Exclusion
- Allergy to Cefoxitin
- Renal or Hepatic insufficiency
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00752908
Start Date
February 1 2008
End Date
June 1 2011
Last Update
September 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barnes Jewish Hospital
St Louis, Missouri, United States, 63110